Transcept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the...

|By:, SA News Editor

Transcept Pharmaceuticals (TSPT) has resumed trading, and is now up 17.6% in the wake of the FDA's approval of its Intermezzo insomnia drug.